Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.-J. Yoo
Rifaximin Treatment Is Associated With Reduced Risk of Cirrhotic Complications and Prolonged Overall Survival in Patients Experiencing Hepatic Encephalopathy
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization
American Journal of Gastroenterology
Hepatology
Gastroenterology
Safety, Efficacy, and Patient Acceptability of Rifaximin for Hepatic Encephalopathy
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Letter: Nutritional Benefits of Rifaximin in Cirrhotic Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Prognostic Factors in Metastatic Pancreatic Cancer: Older Patients Are Associated With Reduced Overall Survival
Molecular and Clinical Oncology
Cancer Research
Oncology
Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients With Acute Variceal Bleeding
Canadian Journal of Gastroenterology and Hepatology
Medicine
Hepatology
Gastroenterology
Risk Factors of Hypoglycemic Encephalopathy and Prolonged Hypoglycemia in Patients With Severe Hypoglycemia
Journal of Clinical Medicine Research
The Impact of Rifaximin-Α on the Hospital Resource Use Associated With the Management of Patients With Hepatic Encephalopathy: A Retrospective Observational Study (IMPRESS)
Frontline Gastroenterology
Hepatology
Gastroenterology
Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials
Journal of Clinical and Experimental Hepatology
Hepatology
High-Dose Glucocorticoids for the Treatment of Ipilimumab-Induced Hypophysitis Is Associated With Reduced Survival in Patients With Melanoma
Cancer
Cancer Research
Oncology
